| Model Number |
453941 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Chest Pain (1776); Thrombosis/Thrombus (4440)
|
| Date of Event |
09/30/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Combination product: yes.
|
| |
|
Event or Problem Description
|
|
An orsiro mission drug-eluting stent system was selected for treatment of the mid cx.Immediately after procedure an in stent thrombosis occurred.Patient developed chest pain.Re-ballooning of the stent was performed and additional heparin was given.
|
| |
|
Additional Manufacturer Narrative
|
|
Combination product: yes, the affected product was not returned to biotronik and could therefore not be subjected to a technical investigation.Images of the case such as angiographies or other relevant clinical information could not be obtained.Review of the production documentation confirmed that the device in question was manufactured according to specifications and fulfilled all the requirements of in?process and final inspection.Based on the reviewed documentation no device deficiency or manufacturing-related root cause could be identified.Since medication was changed after the adverse event, dapt effectiveness may have been a contributing factor to the reported event which could not be confirmed.Please note that, according to the orsiro mission us ifu, administration of appropriate anticoagulant, antiplatelet and vasodilation therapy is critical to successful stent implantation.
|
| |
|
Search Alerts/Recalls
|